MICAL2 and familial pancreatic carcinoma: In conclusion, our study revealed that MICAL2, mainly expressed in fibroblasts, is an independent and adverse prognostic factor and facilitates metastasis and the formation of immunosuppressive microenvironment in pancreatic cancer.